Antithrombotic Forum-3
|
08:00-10:00 206 |
|---|
| 主持 Moderators | 王贵松 Guisong WANG, 唐欧杉 Oushan TANG, 马盛辉 Shenghui MA, 徐曌 Zhao XU, 齐玉波 Yubo QI | ||
|
08:00-08:20 |
从指南变迁看冠心病个体化抗栓的发展趋势 Development Trend of Individualized Antithrombosis in Coronary Heart Disease from the Perspective of Guideline Changes |
钱菊英 Juying QIAN | |
|
08:20-08:40 |
PCI术后抗血小板治疗的最新研究 Latest Research on Antiplatelet Therapy After PCI |
马依彤 Yitong MA | |
|
08:40-09:00 |
冠心病合并房颤患者的抗栓治疗 Antithrombotic Treatment in Patients with Coronary Heart Disease Complicated with Atrial Fibrillation |
苑海涛 Haitao YUAN | |
|
09:00-09:20 |
特殊人群的房颤抗凝治疗 Atrial Fibrillation Anticoagulation in Special Populations |
孟照辉 Zhaohui MENG | |
|
09:20-09:40 |
高出血风险患者PCI术后超短期DAPT策略 Ultra-Short-Term DAPT Strategy After PCI in Patients at High Bleeding Risk |
张邢炜 Xingwei ZHANG | |
|
09:40-10:00 |
2025 抗栓治疗新视野：从国际指南到临床实践 2025 New Perspective on Antithrombotic Treatment: From International Guidelines to Clinical Practice |
程科云 Keyun CHENG | |
Antithrombotic Forum-4
|
10:00-12:00 206 |
|---|
| 主持 Moderators | 袁祖贻 Zuyi YUAN, 韩清华 Qinghua HAN, 李妍 Yan LI, 钟泽 Ze ZHONG, 王卫国 Weiguo WANG, 吴少琴 Shaoqin WU | ||
|
10:00-10:20 |
最新的 PCI 围术期规范化抗栓的治疗策略 Latest Standardized Antithrombotic Treatment Strategy During PCI Perioperative Period |
贾绍斌 Shaobin JIA | |
|
10:40-11:00 |
2025中国心房颤动管理指南解读 Interpretation of the 2025 Chinese Guidelines for the Management of Atrial Fibrillation |
江力勤 Liqin JIANG | |
|
11:00-11:20 |
肾功能不全患者的抗栓治疗策略 Antithrombotic Treatment Strategies for Patients with Renal Insufficiency |
陈晓敏 Xiaomin CHEN | |
|
11:20-11:40 |
泛血管疾病抗栓治疗：探索个体化治疗策略 Antithrombotic Treatment of Pan-Vascular Diseases: Exploring Individualized Treatment Strategies |
唐礼江 Lijiang TANG | |
|
11:40-12:00 |
VTE合并冠心病抗栓策略 Antithrombotic Strategy for VTE Complicated with Coronary Heart Disease |
董鹏 Peng DONG | |
Heart Failure Forum-2
|
13:30-15:30 206 |
|---|
| 主持 Moderators | 马学平 Xueping MA, 陈丽娜 Lina CHEN, 卢孔杰 Kongjie LU, 吕玲春 Lingchun LV, 廉姜芳 Jiangfang LIAN | ||
|
13:30-13:50 |
心衰合并症的管理 Management of Heart Failure Comorbidities |
黎励文 Liwen LI | |
|
13:50-14:10 |
应早尽早——从心衰治疗目标看预防进展的意义 Early Intervention is Essential - Significance of Prevention Progress from the Perspective of Heart Failure Treatment Goals |
陈爱兰 Ailan CHEN | |
|
14:10-14:30 |
中国心衰治疗和指南更新要点（2024） Key Points of Chinese Heart Failure Treatment and Guideline Updates (2024) |
谢伟 Wei XIE | |
|
14:30-14:50 |
从发病机制看心梗后心衰患者优化治疗新选择 Novel Therapeutic Options for Optimizing Management of Heart Failure after Myocardial Infarction: A Pathophysiological Perspective |
李为民 Weimin LI | |
|
14:50-15:10 |
HFrEF合并低血压临床处理策略 Clinical Management Strategy for HFrEF Complicated with Hypotension |
罗素新 Suxin LUO | |
|
15:10-15:30 |
心衰患者的血压管理 Blood Pressure Management in Heart Failure Patients |
李萍 Ping LI | |
Heart Failure Forum-3
|
15:30-17:30 206 |
|---|
| 主持 Moderators | 李为民 Weimin LI, 姜萌 Meng JIANG, 李萍 Ping LI, 金奇志 Qizhi JIN, 蔡元生 Yuansheng CAI | ||
|
15:30-15:50 |
右心导管在心力衰竭中的应用 Application of Right Heart Catheterization in Heart Failure |
徐东杰 Dongjie XU | |
|
15:50-16:10 |
重视心衰合并心肌肥厚的病因解析 Emphasis on Etiological Analysis of Heart Failure Complicated with Myocardial Hypertrophy |
金玮 Wei JIN | |
|
16:10-16:30 |
心衰患者的利尿剂抵抗的应对策略 Coping Strategies for Diuretic Resistance in Heart Failure Patients |
王江 Jiang WANG | |
|
16:30-16:50 |
射血分数改善心衰的现状与管理 Current Status and Management of Heart Failure with Improved Ejection Fraction |
袁璟 Jing YUAN | |
|
16:50-17:10 |
利钠肽系统在心衰全生命周期的作用 Role of the Natriuretic Peptide System in the Whole Life Cycle of Heart Failure |
毛威 Wei MAO | |
|
17:10-17:30 |
讨论 Discussion |
||